首页> 外文期刊>Frontiers in Chemistry >Huanglongmycin A-C, Cytotoxic Polyketides Biosynthesized by a Putative Type II Polyketide Synthase From Streptomyces sp. CB09001
【24h】

Huanglongmycin A-C, Cytotoxic Polyketides Biosynthesized by a Putative Type II Polyketide Synthase From Streptomyces sp. CB09001

机译:黄龙霉素A-C,由链霉菌属的推定的II型聚酮化合物合酶生物合成的细胞毒性聚酮化合物。 CB09001

获取原文
           

摘要

Three natural products of nonaketide biosynthetic origin, probably biosynthesized from nine molecules of malonyl-CoA, have been isolated. Herein we described the isolation and structure elucidation of huanglongmycin (HLM) A-C and identification of the putative hlm biosynthetic gene cluster from Streptomyces sp. CB09001, isolated from a karstic cave in Xiangxi, China. Albeit previously isolated, HLM A was reported for the first time to exhibit moderate cytotoxicity against A549 lung cancer cell line (IC50 = 13.8 ± 1.5 μM) and weak antibacterial activity against gram-negative clinical isolates. A putative biosynthetic pathway for HLM A, featuring a nonaketide-specific type II polyketide synthase, was proposed. It would be consistent with the isolation of HLM B and C, which are two new natural products and likely shunt metabolites during HLM A biosynthesis.
机译:已分离出三种可能由九种丙二酰-CoA分子生物合成的非酰胺类生物合成天然产物。在本文中,我们描述了黄龙霉素(HLM)A-C的分离和结构鉴定以及链霉菌sp的假定hlm生物合成基因簇的鉴定。 CB09001,与中国湘西一个岩溶洞穴隔离。尽管先前已分离出HLM A,但首次报道其对A549肺癌细胞系表现出中等的细胞毒性(IC50 = 13.8±1.5μM),并且对革兰氏阴性临床分离株的抗菌活性较弱。提出了一种推测的HLM A生物合成途径,其特征为非草肽特异性II型聚酮化合物合酶。这与HLM B和C的分离是一致的,HLM B和C是两种新的天然产物,在HLM A生物合成过程中可能会分流代谢产物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号